226
Views
0
CrossRef citations to date
0
Altmetric
Research Article

APOE Polymorphism is Associated with Blood Lipid and Serum uric Acid Metabolism in Hypertension or Coronary Heart Disease in a Chinese Population

, , , &
Pages 1021-1031 | Received 31 Mar 2019, Accepted 15 Jul 2019, Published online: 27 Sep 2019

References

  • National Health Commission of the People’s Republic China Report on Nutrition and Chronic Disease Status of Chinese Residents (2015). People’s Medical Publishing House. Beijing, China (2015). http://en.nhc.gov.cn/
  • Fortson MR , FreedmanSN , RdWP. Clinical assessment of hyperlipidemic pancreatitis. Am. J. Gastroenterol.90(12), 2134 (1995).
  • Chen S , GX , DongSet al. Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study. Clin. Rheumatol.36(5), 1111–1119 (2017).
  • Handelsman Y , ShapiroM. Triglycerides, atherosclerosis, and cardiovascular outcome studies: focus on omega-3 fatty acids. Endocr. Pract.23(1), 100–112 (2017).
  • Emerging Risk Factors Collaboration Di Angelantonio E , SarwarNet al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA302(18), 1993–2000 (2009).
  • Sarwar N , DaneshJ , EiriksdottirGet al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation115(4), 450–458 (2007).
  • Lee JS , ChangPY , ZhangY , KizerJR , BestLG , HowardBV. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes Care40(10), 529–537 (2017).
  • Mahley RW , JrSCR. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet.1(1), 507–537 (2000).
  • Yokoi Y , KondoT , OkumuraNet al. Serum uric acid as a predictor of future hypertension: stratified analysis based on body mass index and age. Prev. Med.90, 201–206 (2016).
  • Kuwabara M , HisatomeI , NiwaKet al. Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study. Hypertension71(1), 78–86 (2018 Jan).
  • Wu AH , GladdenJD , AhmedM , AhmedA , FilippatosG. Relation of serum uric acid to cardiovascular disease. Int. J. Cardiol.213, 4–7 (2016).
  • Horejsí B , CeskaR. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. Physiol. Res.49(Suppl 1(4)), S63 (2000).
  • Singh PP , SinghM , MastanaDSS. APOE distribution in world populations with new data from India and the UK. Ann. Hum. Biol.33(3), 279–308 (2006).
  • Phillips MC . Apolipoprotein E isoforms and lipoprotein metabolism. Iubmb Life66(9), 616–623 (2015).
  • Dallongeville J , LussiercacanS , DavignonJ. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res.33(4), 447–454 (1992).
  • Bazzaz JT , NazariM , NazemHet al. Apolipoprotein E gene polymorphism and total serum cholesterol level in Iranian population. J. Postgrad. Med.56(3), 173–175 (2010).
  • Everaldo DFE , AlvesJG , HutzMH. Apolipoprotein E polymorphism and its association with serum lipid levels in Brazilian children. Hum. Biol.76(2), 267–275 (2004).
  • Fuzikawa AK , PeixotoSV , TauferM , MoriguchiEH , Lima-CostaMF. Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS). Braz. J. Med. Biol. Res.41(2), 89–94 (2008).
  • Xiaotao Li , YD , YanfangDu , XizhengHuang. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clinical and experimental medicine. Clin. Exp. Med.2(4), 175–179 (2003).
  • Bennouar N , AllamiA , LaraquiAet al. Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease. Ann. Biol. Clin.62(3), 295–304 (2004).
  • Cardona F , TinahonesFE , EscuderoA , GarciaFE , SoriguerFJ. The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology42(3), 468–472 (2003).
  • Liberopoulos EN , MiltiadousGA , AthyrosVGet al. Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects. J. Investig. Med.53(3), 116–122 (2005).
  • Jie W , LingQ , Xiu-ZhiGet al. Apolipoprotein E gene polymorphisms are associated with primary hyperuricemia in a Chinese population. PLoS ONE9(10), e110864 (2014).
  • Liu LS . 2010 Chinese guidelines for the management of hypertension. Chin. J. Hypertens.39(2), 579–615 (2011).
  • Antman EM , AnbeDT , ArmstrongPWet al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J. Am. Coll. Cardiol.44(3), E1–E211 (2004).
  • Zannis VI , BreslowJL , UtermannGet al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J. Lipid Res.23(6), 911–914 (1982).
  • Mahley RW . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science240(4852), 622–630 (1988).
  • Niu W , SuXY , QiuC. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J. Hum. Hypertens.21(4), 337–339 (2007).
  • Afroze D , YousufA , TrambooNA , ShahZA , AhmadA. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population. Clin. Exp. Med.16(4), 551–556 (2016).
  • Cheema AN , BhattiA , WangXet al. ApoE gene polymorphism and risk of coronary stenosis in Pakistani population. Biomed. Res. Int.2015, 1–5 (2015).
  • Hallman DM , BoerwinkleE , SahaNet al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet.49(2), 338–349 (1991).
  • Wilson PWF , SchaeferEJ , LarsonMG , OrdovasJM. Apolipoprotein E alleles and risk of coronary disease a meta-analysis. Arterioscle. Thromb. Vasc. Biol.16(10), 1250 (1996).
  • Schiele F , BacquerDe D , Vincent-ViryMet al. Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis152(2), 475–488 (2000).
  • Kosunen O , TalasniemiS , LehtovirtaMet al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke26(5), 743–748 (1995).
  • Gerdes LU . The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin. Chem. Lab. Med.41(5), 628–631 (2003).
  • Ehnholm C , LukkaM , KuusiT , NikkilaE , UtermannG. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J. Lipid Res.27(3), 227–235 (1986).
  • Knijff PD , JohansenLG , RosseneuM , FrantsRR , JespersenJ , HavekesLM. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler. Thromb.12(12), 1371–1379 (1992).
  • Sklavounou E , EconomoupetersenE , KaradimaGet al. Apolipoprotein E polymorphism in the Greek population. Clin. Genet.52(4), 216–218 (2010).
  • Deiana L , PesGM , CarruCet al. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia. Eur. J. Clin. Investig.28(4), 290–294 (2015).
  • Barbagallo CM , PolizziF , SeverinoMet al. ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size. Eur. J. Epidemiol.17(8), 707–713 (2001).
  • Yangchun Zou XH , DayiHu. Correlation between apolipoprotein E gene polymorphism and coronary heart disease in China. Chin. J. Arterioscler.13(3), 355–358 (2005).
  • Jianwei Liu LY , JingLiu. Relationship between apolipoprotein E gene polymorphism and essential hypertension with peripheral arteriosclerosis obliterans. Chin. J. Gerontol.31(19), 3679–3681 (2011).
  • Yingwang Liu JZ , AnZhou. Effects of apolipoprotein E gene polymorphism on blood lipids and hypertension. Chin. J. Arterioscler.10(6), 517–520 (2002).
  • Guobing Zhang HC , ZhiwenJiang. Relationship between apolipoprotein E gene polymorphism and coronary heart disease. Chin. J. Arterioscler.11(4), 310–312 (2001).
  • Tomohiro K , ShunrokuB , KazuhikoIet al. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study. J. Hyperten.20(10), 2017–2021 (2002).
  • Jemaa R , ElasmiM , NaoualiCet al. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin. Biochem.39(8), 816–820 (2006).
  • Medina-Urrutia AX , Cardoso-SaldañaGC , Zamora-GonzálezJ , LiriaYK , Posadas-RomeroC. Apolipoprotein E polymorphism is related to plasma lipids and apolipoproteins in Mexican adolescents. Hum. Biol.76(4), 605–614 (2004).
  • Lixia Yang SL , FengQi. Polymorphism of apolipoprotein E gene and its relationship with blood lipids in patients with coronary heart disease. China J. Modern Med.18(3), 364–366 (2008).
  • Mahley RW , InnerarityTL , RallSC , WeisgraberKH. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res.25(12), 1277–1294 (1984).
  • Knouff C , HinsdaleME , MezdourHet al. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Investig.103(11), 1579–1586 (1999).
  • Khalid Khalaf A , ImranAli K , RabbaniS. Association of apolipoprotein E polymorphism with Type 2 diabetes mellitus in a Saudi population. DNA Cell Biol.33(9), 637–641 (2014).
  • Ellebedy D , RaslanHM , MohammedAM. Apolipoprotein E gene polymorphism and risk of Type 2 diabetes and cardiovascular disease. Cardiovas. Diabetol.15(12), 1–11 (2016).
  • Chen KL , SunYM , ZhouY , ZhaoQH , DingD , GuoQH. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer’s disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China. Psychiatr. Genet.26(3), 124–131 (2016).
  • Agarwal R , TripathiCB. Association of apolipoprotein E genetic variation in Alzheimer’s disease in Indian population: a meta-analysis. Am. J. Alzheimers Dis. Other Demen.29(7), 575–582 (2014).
  • Lu N , DubreuilM , ZhangYet al. Gout and the risk of Alzheimer’s disease: a population-based, BMI-matched cohort study. Ann. Rheumatic Dis.75(3), 547–551 (2016).
  • Sun YP , ZhangB , MiaoLet al. Association of apolipoprotein E (APOE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China. Lipids Health Dis.14, 25 (2015).
  • Suzuki K , KoideD , FujiiK , YamazakiT , TsujiS , IwataA. Elevated serum uric acid levelsare related to cognitive deterioration in an elderly Japanese population. Dement. Geriatr. Cogn. Dis. Extra.6(3), 580–588 (2016).
  • Latourte A , SoumaréA , BardinT , Perez-RuizF , DebetteS , RichetteP. Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study. Ann. Rheum. Dis.77(3), 328–335 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.